Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mem Inst Oswaldo Cruz ; 110(1): 23-47, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25742262

RESUMO

In the Americas, areas with a high risk of malaria transmission are mainly located in the Amazon Forest, which extends across nine countries. One keystone step to understanding the Plasmodium life cycle in Anopheles species from the Amazon Region is to obtain experimentally infected mosquito vectors. Several attempts to colonise Anopheles species have been conducted, but with only short-lived success or no success at all. In this review, we review the literature on malaria transmission from the perspective of its Amazon vectors. Currently, it is possible to develop experimental Plasmodium vivax infection of the colonised and field-captured vectors in laboratories located close to Amazonian endemic areas. We are also reviewing studies related to the immune response to P. vivax infection of Anopheles aquasalis, a coastal mosquito species. Finally, we discuss the importance of the modulation of Plasmodium infection by the vector microbiota and also consider the anopheline genomes. The establishment of experimental mosquito infections with Plasmodium falciparum, Plasmodium yoelii and Plasmodium berghei parasites that could provide interesting models for studying malaria in the Amazonian scenario is important. Understanding the molecular mechanisms involved in the development of the parasites in New World vectors is crucial in order to better determine the interaction process and vectorial competence.


Assuntos
Anopheles/parasitologia , Insetos Vetores/parasitologia , Malária/transmissão , Plasmodium/classificação , Animais , Anopheles/classificação , Anopheles/genética , Anopheles/imunologia , Anopheles/ultraestrutura , Modelos Animais de Doenças , Insetos Vetores/classificação , Insetos Vetores/genética , Insetos Vetores/imunologia , Insetos Vetores/ultraestrutura , Malária/imunologia , Controle de Mosquitos , Carga Parasitária , Floresta Úmida
2.
Trop Med Int Health ; 18(1): 85-95, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23130989

RESUMO

OBJECTIVE: To assess the susceptibility of Trypanosoma cruzi strains from Amazon to benznidazole. METHODS: We studied 23 strains of T. cruzi obtained from humans in the acute phase of Chagas disease, triatomines and marsupials in the state of Amazonas and from chronic patients and triatomines in the state of Paraná, Brazil. The strains were classified as TcI (6), TcII (4) and TcIV (13). For each strain, 20 Swiss mice were inoculated: 10 were treated orally with benznidazole 100 mg/kg/day (TBZ group) for 20 consecutive days and 10 comprised the untreated control group (NT). Fresh blood examination, haemoculture (HC), PCR, and ELISA were used to monitor the cure. RESULTS: The overall cure rate was 60.5% (109/180 mice) and varied widely among strains. The strains were classified as resistant, partially resistant or susceptible to benznidazole, irrespective of discrete typing units (DTUs), geographical origin or host. However, the TcI strains from Amazonas were significantly (P = 0.028) more sensitive to benznidazole than the TcI strains from Paraná. The number of parasitological, molecular and serological parameters that were significantly reduced by benznidazole treatment also varied among the DTUs; the TBZ group of mice inoculated with TcIV strains showed more reductions (8/9) than those with TcI and TcII strains. CONCLUSIONS: Benznidazole resistance was observed among natural populations of the parasite in the Amazon, even in those never exposed to the drug.


Assuntos
Doença de Chagas/tratamento farmacológico , Resistência a Medicamentos/efeitos dos fármacos , Nitroimidazóis/uso terapêutico , Tripanossomicidas/uso terapêutico , Trypanosoma cruzi/efeitos dos fármacos , Animais , Brasil , Doença de Chagas/sangue , Doença de Chagas/parasitologia , Ensaio de Imunoadsorção Enzimática , Humanos , Masculino , Marsupiais , Camundongos , Camundongos Endogâmicos , Nitroimidazóis/farmacologia , Reação em Cadeia da Polimerase , Especificidade da Espécie , Triatominae , Tripanossomicidas/farmacologia , Trypanosoma cruzi/classificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA